+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Implantable Cardiac Rhythm Management Devices - Global Strategic Business Report

  • PDF Icon

    Report

  • 93 Pages
  • April 2023
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5303439

Global Implantable Cardiac Rhythm Management Devices Market to Reach $30.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Implantable Cardiac Rhythm Management Devices estimated at US$17.7 Billion in the year 2022, is projected to reach a revised size of US$30.8 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2022-2030. Pacemaker, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$13.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the ICDs segment is readjusted to a revised 6.9% CAGR for the next 8-year period.

The U.S. Market is Estimated at $4.8 Billion, While China is Forecast to Grow at 11.2% CAGR

The Implantable Cardiac Rhythm Management Devices market in the U.S. is estimated at US$4.8 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6.9 Billion by the year 2030 trailing a CAGR of 11.2% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Abiomed, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic plc
  • Schiller AG
  • ZOLL Medical Corporation

What`s New for 2023?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Frequently Asked Questions about the Global Market for Implantable Cardiac Rhythm Management Devices

What is the estimated value of the Global Market for Implantable Cardiac Rhythm Management Devices?

The Global Market for Implantable Cardiac Rhythm Management Devices was estimated to be valued at $17.7 Billion in 2022.

What is the growth rate of the Global Market for Implantable Cardiac Rhythm Management Devices?

The growth rate of the Global Market for Implantable Cardiac Rhythm Management Devices is 7.2%, with an estimated value of $30.8 Billion by 2030.

What is the forecasted size of the Global Market for Implantable Cardiac Rhythm Management Devices?

The Global Market for Implantable Cardiac Rhythm Management Devices is estimated to be worth $30.8 Billion by 2030.

Who are the key companies in the Global Market for Implantable Cardiac Rhythm Management Devices?

Key companies in the Global Market for Implantable Cardiac Rhythm Management Devices include Abbott Laboratories, Abiomed, Inc., Biotronik SE & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, Schiller AG and ZOLL Medical Corporation.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Impact of Covid-19 and a Looming Global Recession
  • ImplanTable Cardiac Rhythm Management Devices - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for ImplanTable Cardiac Rhythm Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 3: World 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Pacemaker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Pacemaker by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 6: World 16-Year Perspective for Pacemaker by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for ICDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 9: World 16-Year Perspective for ICDs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for CRT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for CRT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 12: World 16-Year Perspective for CRT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 15: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Specialty Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 17: World Historic Review for Specialty Cardiac Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 18: World 16-Year Perspective for Specialty Cardiac Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 20: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 21: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
  • Table 22: World ImplanTable Cardiac Rhythm Management Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • ImplanTable Cardiac Rhythm Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 24: USA Historic Review for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 25: USA 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Product Type - Percentage Breakdown of Value Sales for Pacemaker, ICDs and CRT for the Years 2014, 2023 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: USA Historic Review for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 28: USA 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Cardiac Centers and Other End-Uses for the Years 2014, 2023 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 30: Canada Historic Review for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 31: Canada 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Product Type - Percentage Breakdown of Value Sales for Pacemaker, ICDs and CRT for the Years 2014, 2023 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: Canada Historic Review for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 34: Canada 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Cardiac Centers and Other End-Uses for the Years 2014, 2023 & 2030
JAPAN
  • ImplanTable Cardiac Rhythm Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: Japan Historic Review for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 37: Japan 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Product Type - Percentage Breakdown of Value Sales for Pacemaker, ICDs and CRT for the Years 2014, 2023 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: Japan Historic Review for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 40: Japan 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Cardiac Centers and Other End-Uses for the Years 2014, 2023 & 2030
CHINA
  • ImplanTable Cardiac Rhythm Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 41: China Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 42: China Historic Review for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 43: China 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Product Type - Percentage Breakdown of Value Sales for Pacemaker, ICDs and CRT for the Years 2014, 2023 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: China Historic Review for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 46: China 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Cardiac Centers and Other End-Uses for the Years 2014, 2023 & 2030
EUROPE
  • ImplanTable Cardiac Rhythm Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 48: Europe Historic Review for ImplanTable Cardiac Rhythm Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 49: Europe 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: Europe Historic Review for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 52: Europe 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Product Type - Percentage Breakdown of Value Sales for Pacemaker, ICDs and CRT for the Years 2014, 2023 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 54: Europe Historic Review for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 55: Europe 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Cardiac Centers and Other End-Uses for the Years 2014, 2023 & 2030
FRANCE
  • ImplanTable Cardiac Rhythm Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 56: France Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: France Historic Review for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 58: France 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Product Type - Percentage Breakdown of Value Sales for Pacemaker, ICDs and CRT for the Years 2014, 2023 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 60: France Historic Review for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 61: France 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Cardiac Centers and Other End-Uses for the Years 2014, 2023 & 2030
GERMANY
  • ImplanTable Cardiac Rhythm Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany Historic Review for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 64: Germany 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Product Type - Percentage Breakdown of Value Sales for Pacemaker, ICDs and CRT for the Years 2014, 2023 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 66: Germany Historic Review for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 67: Germany 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Cardiac Centers and Other End-Uses for the Years 2014, 2023 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy Historic Review for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 70: Italy 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Product Type - Percentage Breakdown of Value Sales for Pacemaker, ICDs and CRT for the Years 2014, 2023 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 72: Italy Historic Review for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 73: Italy 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Cardiac Centers and Other End-Uses for the Years 2014, 2023 & 2030
UNITED KINGDOM
  • ImplanTable Cardiac Rhythm Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 75: UK Historic Review for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 76: UK 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Product Type - Percentage Breakdown of Value Sales for Pacemaker, ICDs and CRT for the Years 2014, 2023 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 78: UK Historic Review for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 79: UK 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Cardiac Centers and Other End-Uses for the Years 2014, 2023 & 2030
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 81: Spain Historic Review for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 82: Spain 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Product Type - Percentage Breakdown of Value Sales for Pacemaker, ICDs and CRT for the Years 2014, 2023 & 2030
  • Table 83: Spain Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 84: Spain Historic Review for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 85: Spain 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Cardiac Centers and Other End-Uses for the Years 2014, 2023 & 2030
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 87: Russia Historic Review for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 88: Russia 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Product Type - Percentage Breakdown of Value Sales for Pacemaker, ICDs and CRT for the Years 2014, 2023 & 2030
  • Table 89: Russia Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 90: Russia Historic Review for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 91: Russia 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Cardiac Centers and Other End-Uses for the Years 2014, 2023 & 2030
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Product Type - Percentage Breakdown of Value Sales for Pacemaker, ICDs and CRT for the Years 2014, 2023 & 2030
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 97: Rest of Europe 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Cardiac Centers and Other End-Uses for the Years 2014, 2023 & 2030
ASIA-PACIFIC
  • ImplanTable Cardiac Rhythm Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for ImplanTable Cardiac Rhythm Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for ImplanTable Cardiac Rhythm Management Devices by Product Type - Pacemaker, ICDs and CRT Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by Product Type - Percentage Breakdown of Value Sales for Pacemaker, ICDs and CRT for the Years 2014, 2023 & 2030
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for ImplanTable Cardiac Rhythm Management Devices by End-Use - Hospitals, Specialty Cardiac Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
  • Table 106: Asia-Pacific 16-Year Perspective for ImplanTable Cardiac Rhythm Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Specialty Cardiac Centers and Other End-Uses for the Years 2014, 2023 & 2030
AUSTRALIA
  • ImplanTable Cardiac Rhythm Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • ImplanTable Cardiac Rhythm Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • ImplanTable Cardiac Rhythm Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • ImplanTable Cardiac Rhythm Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • ImplanTable Cardiac Rhythm Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • Abiomed, Inc.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cardiac Science Corporation
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic plc
  • Schiller AG
  • ZOLL Medical Corporation